Among the five different muscarinic receptors that have been cloned and characterized, M2 and M4 receptors are localized both post-and presynaptically and are believed to have a pronounced autoreceptor role. The functional importance of these receptors in the regulation of acetylcholine release in the hippocampus and in cognitive processes was investigated by using M2 and M4 receptor single knockout (KO) as well as M2/M4 receptor double KO mice. We found profound alterations in acetylcholine homeostasis in the hippocampus of both M2-and M4-KO mice as well as of the combined M2/M4-KOs, as assessed by in vivo microdialysis. Basal acetylcholine efflux in the hippocampus was significantly increased in M4-KO and was elevated further in M2/M4-KOs. The increase in hippocampal acetylcholine induced by local administration of scopolamine was markedly reduced in M2-KO and completely abolished in M2/M4-KOs. In M2-KO and much more in M2/M4-KOs, the increase in hippocampal acetylcholine triggered by exposure to a novel environment was more pronounced both in amplitude and duration, with a similar trend observed for M4-KOs. Dysregulation of cholinergic function in the hippocampus, as it could result from perturbed autoreceptor function, may be associated with cognitive deficits. Importantly, M2-and M2/M4-KO, but not M4-KO, animals showed an impaired performance in the passive avoidance test. Together these results suggest a crucial role for muscarinic M2 and M4 receptors in the tonic and phasic regulation of acetylcholine efflux in the hippocampus as well as in cognitive processes.
Introduction
In the central nervous system (CNS), muscarinic receptors act postsynaptically to modulate neurotransmission mediated by other ionotropic and metabotropic receptors, and presynaptically as heteroreceptors that regulate the release of a number of neurotransmitters or as autoreceptors that regulate acetylcholine release. 1, 2 Muscarinic receptors play an important role in many brain functions including cognition, vigilance, affect, nociception and sensorimotor gating. [3] [4] [5] Muscarinic receptor dysfunction has been associated with a number of diseases of the CNS such as Parkinson's disease 6 and Alzheimer's disease. 7, 8 Evidence from animal studies also suggests a role for muscarinic receptors in the pathophysiology of psychosis. 9, 10 Ligands specific for muscarinic receptor subtypes could be promising as therapeutic targets for these pathologies. However, research in this field has been impeded because of the complex pharmacology of muscarinic receptors. 8, 11 Five distinct muscarinic acetylcholine receptors (M1-M5) have been cloned and characterized, all of which belong to the superfamily of G-protein-coupled receptors. Expression models have established the signal transduction pathways mediating the actions of each subtype. M1, M3 and M5 are primarily coupled to G q/11 and stimulate the inositol phosphate pathway, while M2 and M4 are coupled to G i/o and mediate inhibition of adenylyl cyclase activity. 12, 13 Radioligand binding, in situ hybridization and immunocytochemical studies have permitted expression mapping of each subtype in the periphery as well as in the CNS where all receptors are present with highly overlapping patterns. 2 Much less is known about the distinct biological roles of each of the five muscarinic receptor subtypes. The lack of subtype-specific muscarinic ligands has made it difficult to determine the functional importance of M1-M5 receptors with classical pharmacological studies. Progress has been made recently by the use of molecular genetic approaches. Antisense 14, 15 and gene targeting technologies have emerged as powerful new tools in identifying the receptor subtypes involved in various muscarinic cholinergic functions. [16] [17] [18] [19] [20] [21] Although pharmacological, neuroanatomical and clinical studies have suggested an important role of muscarinic receptors in synaptic plasticity and memory, the functions of the individual muscarinic receptor subtypes remain unclear. In this study, we have used M2 and M4 receptor single knockout (KO) as well as M2/M4 receptor double KO mice to investigate the functional importance of M2 and M4 receptors in the regulation of acetylcholine release in the hippocampus and in cognitive processes.
Materials and methods

Animals
The generation of M2-and M4-KO mice was described previously.
9,17 M2/M4 double KO mice were generated by intermating homozygous M2 and M4 receptor KO mice. 22 In this study, we have used male adult mice that genetically were 129J1 Â CF-1 hybrids (M2-KOs and corresponding wild-type (WT) mice), 129SvEv Â CF-1 hybrids (M4-KOs and corresponding WT mice) or 129J1 Â 129SvEv Â CF-1 hybrids (M2/M4 double KOs and corresponding WT mice). Mouse genotyping was carried out by PCR analysis of mousetail DNA. Adult (3-6 months old) male mice were used in this study.
Surgical procedures
Experiments in animals were conducted according to the guidelines of the Animal Care Committee of Eli Lilly and Company. Mice were implanted unilaterally in the hippocampus (AP: À3.3, ML: þ 3.1, DV: À4.2) with 2 mm microdialysis probes (CMA, Stockholm, Sweden) under anesthesia with a mixture of chloral hydrate and pentobarbital. Mice were left to recover from the surgery for 30-36 h. The correct placement of the probe was verified histologically at the end of the experiment.
In vivo microdialysis
The morning of the experiment, mice were placed into the testing cage, a cylinder of 15 cm Â 25 cm made of transparent Plexiglas containing saw bedding. The mice were perfused in the hippocampus with an artificial Ringer's solution 23 supplemented with 0.33 mM neostigmine, at a flow rate of 1.5 ml/min and were left to acclimate to this setting for 4 h. Throughout the experiment, dialysate samples were collected every 15 min and analyzed on-line, for acetylcholine. After the initial 4 h period, little variation (less than 10%) was observed in the corresponding acetylcholine signal between the 15 min samples. Acetylcholine baseline was establishedFas the average of five 15 min samples prior to any manipulationFand the experiment started. For the exposure to novelty experiments, the mice were transferred to a new cage of approximately the same size but markedly different in texture and color (rubber, dark red) from the testing cage (Plexiglas, transparent). In addition, the novel cage did not contain saw bedding. The mice remained in this novel environment for 1 h and then were transferred back to their testing cage. Samples were collected for an additional period of 1 h. For pharmacological experiments, the mice were infused with scopolamine (1 and 10 mM) in the hippocampus through the microdialysis probe for 45 min. Scopolamine was diluted directly in the perfusion solution to the appropriate final concentration, immediately prior to the experiment. Dialysates were analyzed on-line for acetylcholine by HPLC coupled to electrochemical detection as described. 24 Statistical analysis was performed using two-way (Genotype Â Strain or Time or Drug Concentration) ANOVA and Duncan's post hoc test. For novelty experiments, data are expressed as multifold changes from the baseline for each experimental time point. For pharmacological experiments, data are presented as multifold average changes from the baseline for the 45-min period during which the drug was infused.
Passive avoidance response Passive avoidance performance was assessed in eight shuttle-box chambers for mice (Coulbourn Instruments) in which one side of the shuttle-box was darkened and a 1.96 W light illuminated the other. On Day 1 (Training), mice were individually confined to the aversive lighted side of the shuttle-box chamber for 3 min, after which the shuttle door was raised and the mice were allowed to enter the preferred darkened chamber. The mice received an inescapable 2-s footshock (0.75 mA) 2 s after entering the dark chamber, and were removed from the chamber 10 s later. On Day 2 (Testing), the mice were again confined to the lighted chamber for 3 min, after which the shuttle door was raised and access to the darkened chamber was given. No footshock was administered and a maximum latency of 300 s was recorded. The latency (s) to enter the darkened chamber on both training and testing days was the dependent measure. Latency to cross to the dark side of the shuttle chamber was analyzed in a Genotype Â Day ANOVA.
Results
Increased basal acetylcholine levels in the hippocampus of M4-and M2/M4-KO mice Prior to each experimental manipulation, basal acetylcholine levels were measured in the hippocampus of M2-, M4-and M2/M4-KO mice and their corresponding WT. Basal acetylcholine levels were not significantly different between M2-, M4-and M2/ M4-WT mice. Basal hippocampal acetylcholine levels were not affected by the lack of M2 receptors ( Figure 1 ). On the contrary, basal hippocampal acetylcholine levels were significantly higher in M4-KO mice, and even more so in M2/M4-KOs as compared to the corresponding WT mice (two-way ANOVA interaction effect, F(2,32) ¼ 5.45, Po0.01).
The effects of scopolamine on acetylcholine efflux in the hippocampus are abolished in M2/M4-KO mice. Infusion of scopolamine, a nonsubtype-selective muscarinic antagonist, locally into the hippocampus produced a marked, dose-dependent increase in acetylcholine in this region, in WT mice ( Figure 2 Figure 2c ). It should be noted that the effects of muscarinic receptor antagonists, such as scopolamine, on acetylcholine efflux are accentuated in the presence of cholinesterase inhibitors, such as neostigmine, in the perfusion solution. [25] [26] [27] [28] Still, under the present experimental conditions, differences in the responses to scopolamine between WT and KO mice were detected reflecting differences in the autoregulation of acetylcholine release as a result of the presence or absence of muscarinic receptors.
Altered hippocampal acetylcholine efflux in response to novelty in M2/M4-KO mice In all three strains of WT mice, exposure to a novel environment produced a two-fold transient increase in acetylcholine efflux in the hippocampus; acetylcholine levels rapidly declined and did not differ significantly from baseline levels after 30 min of exposure to the new environment (Figure 3) . In M2/ M4-KO mice, this increase was much more pronounced both in amplitude and in duration (F(8,24) ¼ 2.41, Po0.05). A significant increase in the amplitude of this response was also observed for the M2-KOs (interaction F(8,32) ¼ 2.31, Po0.05), whereas the M4-KOs showed a similar trend (interaction F(8,40) ¼ 0.56, n.s.). After 1 h of exposure in the novel environment, the mice were brought back to their testing cage. In contrast to what we observed when the mice were exposed to the novel environment, there was no significant change in acetylcholine levels in M2-and M2/M4-WT animals when brought back to the testing cage. On the contrary, in M2-and M2/M4-KO mice, we observed a marked and significant increase in hippocampal acetylcholine when the mice returned to the testing cage. There was no difference in the response between M4-KO mice and M4-WT mice upon return to the testing cage. It should be noted that lifting the animals up and injecting them intraperitoneally with saline did not significantly affect acetylcholine efflux in the hippocampus of the WT or the KO mice (n ¼ 4, data not shown).
Impaired passive avoidance response in M2-and M2/M4-KO mice In the passive avoidance paradigm, analysis of the M2-KO and -WT mice revealed that significant memory retention was observed in the mice (Figure 4) . 
Discussion
Muscarinic receptors are known to act as autoreceptors regulating acetylcholine release in the periphery as well as in the central nervous system. Elucidation of the mechanisms governing autoregulation of acetylcholine release in the hippocampus is of interest because of the proposed involvement of cholinergic hippocampal pathways in cognitive processes. In that context, it has been well established that a number of muscarinic antagonists stimulate acetylcholine release from rat hippocampal slices. 25 Similarly, consistent with a direct autoreceptor function of muscarinic receptors, in vivo microdialysis studies in the hippocampus showed that muscarinic receptor antagonists increase acetylcholine release, an effect that is dependent on the presence of acetylcholinesterase inhibitors in the synaptic cleft. [26] [27] [28] Converging biochemical, pharmacological and neuroanatomical evidence has singled out the M2 and M4 receptors as being the major autoreceptors acting in hippocampal circuits. These two receptor subtypes activate G proteins of the G i family, and numerous reports have localized them in presynaptic axon terminals. 2, 29 Presynaptic localization of M2 and M4 receptors in the hippocampus shows complementary patterns among the commissural/associational, perforant and septohippocampal pathways, and applies to both cholinergic and noncholinergic terminals. 8, 29, 30 Furthermore, because of the lack of subtype-specific ligands, contradictory results have been reported regarding the role of specific muscarinic receptor subtypes in regulating hippocampal cholinergic neurotransmission. For example, inhibitory muscarinic autoreceptors in the hippocampus have been classified as M2, M4, or as a mixture of M1 and M4 receptors 25, 31, 32 (reviewed by Vizi and Kiss
33
). AF-DX384 and its derivatives commonly used to define the 'M2' pharmacological muscarinic-receptor class have similar affinities for cloned M2 and M4 receptors 34 and their action was blocked by either M2 or M4 antisense oligonucleotides. 14 In the present study, we show that both M2 and M4 receptors regulate acetylcholine release in the hippocampus, but with distinct roles. In M4-KO mice, basal acetylcholine levels are increased, while in M2-KO mice, basal acetylcholine levels are unaltered compared to M2-WT mice. These results suggest that M4 receptors play a predominant role in a tonic autoregulatory pathway that controls acetylcholine release. It would be important to further investigate the molecular mechanisms and the functional significance of this regulation. Basal acetylcholine levels in double M2/M4-KO mice are even higher than in the single M4-KO animals, suggesting that M2 receptors also contribute to the inhibition of basal acetylcholine release. However, this contribution remained undetected in the M2 single KO mice, probably because of the presence of the predominant M4 receptor pathway. Previous studies with M2 and M4 receptorspecific antibodies have shown that inactivation of the M2 receptor gene did not lead to changed M4 receptor expression levels in the hippocampus and vice versa.
9,17
On the other hand, the increase in acetylcholine release produced by the nonselective muscarinic antagonist scopolamine was attenuated in M2-but not M4-KO mice. In agreement with the present findings, oxotremorine-induced reduction in stimulated [ 3 H]acetylcholine release from hippocampal slices was abolished in M2-KO animals but preserved in M4-KOs. 22 Consistent with the notion that M2 receptors are particularly important in mediating the presynaptic effects of muscarinic agonists and antagonists in the hippocampus, Kitaichi et al 14 reported that M2 but not M4 antisense treatment prevented the stimulatory effects of the mixed M2/M4 antagonist AF-DX384 on acetylcholine release in this region. It should be noted, however, that although the effects of scopolamine are completely abolished in M2/M4-KO mice, they are only diminished in M2-KOs. This suggests that the loss of M4 receptors also contributes to the scopolamine-induced increase in acetylcholine levels in the hippocampus. It is likely that this contribution remained undetected in the M4-KO mice because of the activity of the more dominant M2 receptor pathway.
In view of the apparent dual mode of action of M2 and M4 receptors, we further investigated the functional importance of M2 and M4 receptor-mediated regulation of acetylcholine release in the hippocampus. Specifically, WT and KO mice were exposed to a new environment. Exposure to a novel environment has been shown to transiently increase cholinergic neurotransmission in the hippocampus. [35] [36] [37] [38] [39] In M2-KOs and much more in M2/M4-KOs, the increase in hippocampal acetylcholine triggered by exposure to a novel environment was more pronounced both in amplitude and duration as compared to WT mice. This enhancement in the acetylcholine response in the KO mice could be a consequence of a number of distinct phenomena, including an increase in acetylcholine synthesis or a reduction in catabolism. However, differences in acetylcholine turnover are unlikely to occur given that basal levels of acetylcholine are unchanged in M2-KO mice as compared to WT control mice. It is more likely that the excessive acetylcholine release observed in M2-and M2/M4-KO mice is because of the lack of inhibitory muscarinic autoreceptors mediating feedback inhibition of evoked acetylcholine release. This hypothesis is further supported by the fact that the hyper-responsiveness of cholinergic hippocampal neurons in M2-and M2/M4-KO mice persists also when the KO mice are brought back to their familiar environment. It should be noted that agents that acutely increase acetylcholine synthesis cause a larger increase in hippocampal acetylcholine levels upon exposure to the novel environment, but do not affect the response of the animals upon return to their home cage. 35 Taken together, the observed differences in acetylcholine responses between the KO and the WT mice can be attributed to impaired autoreceptor function, involving particularly M2 receptors. The data obtained with the M2/M4 double KO mice suggest that M4 receptors that control tonic acetylcholine release may play a secondary role in mediating autoinhibition of acetylcholine release.
Physiological responses triggered by novelty involve several components including arousal, attention and stress. Increases in cholinergic activity in the forebrain upon exposure to novelty (novel environment or other unconditioned stimulus such as light or tone) are believed to reflect primarily arousal by and/ or attention to behaviorally salient stimuli [37] [38] and to a lesser extent exploratory activity or fear. 36, 38 Increases in hippocampal acetylcholine release produced by unconditioned stimuli are significantly reduced by between-and within-session habituation. 38 Novelty-induced increases in acetylcholine release are transient, peaking at the first 10-15 min after presentation of the stimulus and steadily decreasing afterwards. Furthermore, re-exposure to an already presented stimulus results in a significantly attenuated acetylcholine release in comparison with the first exposure, as a result of recall and habituation. 36, 38 The excessively elevated acetylcholine release in the hippocampus of M2-and M2/M4-KO mice when brought back to their home cage (exposure to a familiar environment) might suggest a habituation deficit in these mice. Habituation, defined as a diminished response owing to familiarity, provides one of the most elementary forms of learning both in animals and in humans, and requires learning-related processes and recognition or recall. [39] [40] [41] To test the possibility that abnormally elevated acetylcholine efflux in M2-and M2/M4-KO mice might be associated with habituation deficits and cognitive impairment, the performance of M2-, M4-and M2/M4-KO mice was assessed in the passive avoidance test. Although the passive avoidance paradigm is a nonspecific aversive memory test that involves a number of brain structures, it exhibits well-documented validity in depicting memory impairments as a result of aging, or pharmacological and genetic manipulations. [42] [43] [44] [45] [46] Acquisition and/or retention in the passive avoidance test are dependent on the integrity of the hippocampal cholinergic pathway. 35, [42] [43] [44] 47, 48 M2-and M2/M4-KO mice, but not M4-KO mice, showed impaired memory retention in the passive avoidance paradigm. These deficits were reminiscent of those produced by the nonselective muscarinic antagonist scopolamine or by ligands that impair cognition by dysregulating cholinergic neurotransmission at the level of the septohippocampal pathway. [42] [43] [44] [45] 49, 50 Dysregulated acetylcholine release in response to environmental stimuli and deficits in the passive avoidance paradigm are not likely to be because of nonspecific phenotypic alterations such as hyperlocomotion in the KO mice. In fact, M4-KO mice that display increased basal locomotor activity 9 do not show deficits in the passive avoidance, whereas M2-KO mice, that perform poorly in the passive avoidance test, display normal locomotor activity (unpublished observations). There is contradictory evidence regarding the effects of M2 antagonists on memory and cognitive performance. The M2 receptor-preferring antagonist BIBN99 improved the performance of aged rats in the Morris-water-maze, 51 the M2/M4 antagonist AF-DX384 reversed memory impairments in old rats 42 and the more selective M2 antagonist SCH 57790 enhanced cognitive performance in rodents and in nonhuman primates. 52 On the other hand, intrahippocampal administration of the putative M2 antagonist gallamine led to impaired performance in a T-maze working memory task, 53 and BIBN99 counteracted the estrogen-induced enhancement of working memory in the rat. 54 Our data show that M2 receptor function is necessary for the full development of learning and memory in the passive avoidance test. Complex interactions between cholinergic pathways and other neurotransmitters, operating in a dynamic balance at multiple levels and at the appropriate time frame in the hippocampus, appear to be key elements for proper information processing. Aberrations in the fine-tuning of muscarinic cholinergic neurotransmission, as those described in the present study, could therefore negatively affect higher cognitive processes and may account for the poor performance of these mice in the passive avoidance test.
In summary, our data show that both M2 and M4 receptors regulate acetylcholine release in the hippocampus. However, the two receptors have distinct but complementary functions. The M4 receptor participates in a tonic regulatory loop that controls basal acetylcholine levels, whereas the M2 receptor plays a key role in regulating pharmacologically and physiologically evoked acetylcholine release. Importantly, this latter activity seems to be required for the full development and expression of mnemonic and cognitive events.
